-
公开(公告)号:CY1119001T1
公开(公告)日:2018-01-10
申请号:CY171100480
申请日:2017-05-03
Applicant: PTC THERAPEUTICS INC
Inventor: KARP GARY MITCHELL , HWANG SEONGWOO , CHEN GUANGMING , ALMSTEAD NEIL GREGORY , MOON YOUNG-CHOON
IPC: C07D271/06 , A61K31/4245 , A61P35/00 , C07D271/12 , C07D413/04 , C07D413/10
Abstract: Ηπαρούσαεφεύρεσηαφοράσεμίαένωση 3-[5-(2-Φθορο-φαινυλ)-[1,2,4]οξαδιαζολ-3-υλ]-βενζοϊκούοξέος, πουέχειτησύνταξη:ήφαρμακευτικώςαποδεκτόάλαςαυτής. Ηπαρούσαεφεύρεσηεπίσηςαφοράσεφαρμακευτικήσύνθεσηκαιμίααπλήδοσολογίαμονάδαςαυτής, καθώςεπίσηςστηνενλόγωένωσηγιαχρήσησεμίαμέθοδοθεραπείας, αποτροπήςή βελτίωσηςασθενειώνόπωςορίζονταιστοπαρόν.
-
公开(公告)号:DK2910551T3
公开(公告)日:2017-05-15
申请号:DK14188816
申请日:2004-04-09
Applicant: PTC THERAPEUTICS INC
Inventor: KARP GARY MITCHELL , HWANG SEONGWOO , ALMSTEAD NEIL GREGORY , MOON YOUNG-CHOON , CHEN GUANGMING
IPC: C07D271/06 , A61K31/4245 , A61P35/00 , C07D271/12 , C07D413/04 , C07D413/10
-
公开(公告)号:CA2647903C
公开(公告)日:2016-12-13
申请号:CA2647903
申请日:2007-03-29
Applicant: PTC THERAPEUTICS INC
Inventor: ALMSTEAD NEIL G , CHEN GUANGMING , HIRAWAT SAMIT , HWANG SEONGWOO , KARP GARY M , MILLER LANGDON , MOON YOUNG-CHOON , REN HONGYU , TAKASUGI JEMES J , WELCH ELLEN M , WILDE RICHARD G , KENNEDY PAUL
IPC: A61K31/00 , A61K31/40 , A61K31/41 , A61K31/4162 , A61K31/44 , A61K31/46 , A61P1/00 , A61P5/00 , A61P25/28
Abstract: The present invention relates to functional proteins encoded by nucleic acid sequences comprising a nonsense mutation. The present invention also relates to methods for the production of functional proteins encoded by nucleic acid sequences comprising a nonsense mutation and the use of such proteins for prevention, management and/or treatment of diseases associated with a nonsense mutation(s) in a gene.
-
84.
公开(公告)号:IN4406CHN2014A
公开(公告)日:2015-09-04
申请号:IN4406CHN2014
申请日:2014-06-13
Applicant: PTC THERAPEUTICS INC
Inventor: ALMSTEAD NEIL G , CHEN GUANGMING , HIRAWAT SAMIT , HWANG SEONGWOO , KARP GARY M , MILLER LANGDON , MOON YOUNG-CHOON , REN HONGYU , TAKASUGI JAMES J , WELCH ELLEN M , WILDE RICHARD G , KENNEDY PAUL
IPC: A61K31/00
Abstract: This invention relates to an oral pharmaceutical composition comprising an effective amount of 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid or a pharmaceutically acceptable salt, thereof, a suspending agent selected from refined polydextrose, a binding agent selected from mannitol, surfactant agents selected from polyethylene glycol 3350 and poloxamer 407 powder, a disintegrant selected from crospovidone, and other excipients selected from hydroxyethyl cellulose, vanilla flavor, magnesium stearate and colloidal silica; wherein the effective amount of 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid or a pharmaceutically acceptable salt is determined according to patient weight.
-
公开(公告)号:ES2528195T3
公开(公告)日:2015-02-05
申请号:ES04759404
申请日:2004-04-09
Applicant: PTC THERAPEUTICS INC
Inventor: KARP GARY MITCHELL , HWANG SEONGWOO , CHEN GUANGMING , ALMSTEAD NEIL GREGORY , MOON YOUNG-CHOON
IPC: C07D271/06 , A61K31/4245 , A61P35/00 , C07D271/12 , C07D413/04 , C07D413/10
Abstract: Un compuesto de fórmula (I):**Fórmula** en donde: Z es arilo sustituido diferente de 4-cianofenilo, heteroarilo sustituido o sin sustituir seleccionado entre triazolilo, tetrazolilo, oxadiazolilo, furilo, benzofuranilo, tiofenilo, benzotiofenilo, benzoisoxazolilo, benzoisotiazolilo, quinolinilo, pirrolilo, indolilo, oxazolilo, benzoxazolilo, bencimidazolilo, benzotiazolilo, isoxazolilo, pirazolilo, isotiazolilo, piridazinilo, pirazinilo, triazinilo, cinnolinilo, ftalazinilo, quinazolinilo, benzoquinazolinilo o acridinilo, cicloalquilo sustituido o sin sustituir, alquenilo sustituido o sin sustituir, heterociclo sustituido o sin sustituir seleccionado entre morfolinilo, pirrolidinonilo, pirrolidinilo, hidantoinilo, valerolactamilo, oxiranilo, oxetanilo, tetrahidrofuranoílo, tetrahidropiranilo, tetrahidrotiofenilo o tetrahidrotiopiranilo, arilalquilo sustituido o sin sustituir; o Z es p-tolilo; (4-clorometil-fenilo); (4-etil-fenilo); o-tolilo; (3-metil-tiofen-2-ilo); (4-terc-butil-fenilo); m-tolilo; (2,5-dimetil-furan-3-ilo); (4-pirrol-1-il-fenilo); (4-nitro-fenilo); (4-isobutil-fenilo); [3-(2-cloro-6-fluoro-fenil)-5-metil-isoxazol-4-ilo]; o [3-(2-cloro-fenil)-5-metil-isoxazol-4-ilo]; R1 es hidrógeno, alquilo sustituido o sin sustituir, cicloalquilo sustituido o sin sustituir, heterocicloalquilo sustituido o sin sustituir, arilo sustituido o sin sustituir, heteroarilo sustituido o sin sustituir, o -(CH2CH2O)nR6; R2, R3, R4, y R5 son independientemente hidrógeno, alcoxi o halógeno; R6 es hidrógeno o alquilo; n es un número entero de 1 a 7; y el término "sustituido" significa un grupo sustituido por uno a cuatro sustituyentes, seleccionados entre halo, trifluorometilo, trifluorometoxi, hidroxi, alcoxi, cicloalquiloxi, heterociclooxi, oxo, alcanoílo, alquilcarbonilo, cicloalquilo, arilo, ariloxi, aralquilo, alcanoiloxi, ciano, azido, amino, alquilamino, arilamino, aralquilamino, cicloalquilamino, heterocicloamino, o amino mono y disustituido en que el uno o dos sustituyentes en el grupo amino se seleccionan entre alquilo; en donde cuando los propios sustituyentes están adicionalmente sustituidos, dichos sustituyentes adicionales se seleccionan del grupo que consiste en halógeno, alquilo, alcoxi, arilo y aralquilo; o una sal, solvato o hidrato del mismo farmacéuticamente aceptable.
-
86.
公开(公告)号:DK1618098T3
公开(公告)日:2015-01-12
申请号:DK04759404
申请日:2004-04-09
Applicant: PTC THERAPEUTICS INC
Inventor: KARP GARY MITCHELL , HWANG SEONGWOO , CHEN GUANGMING , ALMSTEAD NEIL GREGORY , MOON YOUNG-CHOON
IPC: C07D271/06 , A61K31/4245 , A61P35/00 , C07D271/12 , C07D413/04 , C07D413/10
-
公开(公告)号:CA2559408C
公开(公告)日:2014-05-13
申请号:CA2559408
申请日:2005-03-15
Applicant: PTC THERAPEUTICS INC
Inventor: MOON YOUNG-CHOON , CAO LIANGXIAN , TAMILARASU NADARAJAN , QI HONGYAN , CHOI SOONGYU , LENNOX WILLIAM JOSEPH , CORSON DONALD THOMAS , HWANG SEONGWOO
IPC: C07D471/04 , A61K31/437 , A61K31/4545 , A61K31/4745 , A61K31/497 , A61K31/506 , A61K31/5355 , A61K31/5377 , A61K31/541 , A61K31/551 , A61K31/724 , A61P35/00
Abstract: In accordance with the present invention, compounds that inhibit the expression of VEGF post-transcriptionally have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the inhibition of VEGF production, in the inhibition of angiogenesis, and/or in the treatment of cancer, diabetic retinopathy or exudative macular degeneration are provided. In another aspect of the invention, methods are provided for the inhibition of VEGF production, the inhibition of angiogenesis, and/or the treatment of cancer, diabetic retinopathy or exudative macular degeneration using the compounds of the invention.
-
公开(公告)号:AU2007235524B2
公开(公告)日:2013-09-12
申请号:AU2007235524
申请日:2007-03-29
Applicant: PTC THERAPEUTICS INC
Inventor: REN HONGYU , HIRAWAT SAMIT , WELCH ELLEN M , WILDE RICHARD G , ALMSTEAD NEIL G , KARP GARY M , MOON YOUNG-CHOON , TAKASUGI JEMES J , MILLER LANGDON , CHEN GUANGMING , HWANG SEONGWOO
IPC: A61K31/00 , A61K31/40 , A61K31/41 , A61K31/4162 , A61K31/44 , A61K31/46 , A61P1/00 , A61P5/00 , A61P25/28
Abstract: The present invention relates to functional proteins encoded by nucleic acid sequences comprising a nonsense mutation. The present invention also relates to methods for the production of functional proteins encoded by nucleic acid sequences comprising a nonsense mutation and the use of such proteins for prevention, management and/or treatment of diseases associated with a nonsense mutation(s) in a gene.
-
公开(公告)号:PT1737461E
公开(公告)日:2013-03-18
申请号:PT05725560
申请日:2005-03-15
Applicant: PTC THERAPEUTICS INC
Inventor: MOON YOUNG-CHOON , CAO LIANGXIAN , TAMILARASU NADARAJAN , QI HONGYAN , CHOI SOONGYU , LENNOX WILLIAM JOSEPH , CORSON DONALD THOMAS , HWANG SEONGWOO
IPC: A61K31/497 , A61K31/437 , A61K31/4745 , A61K31/506 , A61K31/5355 , A61K31/541 , A61K31/551 , A61K31/724 , A61P35/00 , C07D471/04
-
公开(公告)号:AT548354T
公开(公告)日:2012-03-15
申请号:AT03766012
申请日:2003-07-23
Applicant: PTC THERAPEUTICS INC
Inventor: WILDE RICHARD , TAKASUGI JAMES , HWANG SEONGWOO , WELCH ELLEN , CHEN GUANGMING
IPC: C07D233/42 , A61K31/17 , A61K31/4166 , A61P35/00 , C07C275/42 , C07D233/32 , C07D233/70 , C07D233/72 , C07D233/78 , C07D233/84 , C07D285/16 , C07D401/04 , C07D401/10 , C07D405/04 , C07D405/06 , C07D409/04
Abstract: The invention encompasses ureido substituted benzoic acid compounds, compositions comprising the compounds and methods for treating or preventing diseases associated with nonsense mutations of mRNA by administering these compounds or compositions.
-
-
-
-
-
-
-
-
-